Consistent with these results, animal death was within 38-42 days after ZDHHC17-expressing GSC injection (Figure 7I), whereas MAP2K4 knockdown or genistein injection inhibited tumor growth and extended the survival of animals implanted with ZDHHC17-expressing cells. The gene discussed is MAP2K4; the disease is neoplasm.